MedPath
HSA Approval

ULTRAFEN 12.5 SUPPOSITORY 12.5 mg

SIN10523P

ULTRAFEN 12.5 SUPPOSITORY 12.5 mg

ULTRAFEN 12.5 SUPPOSITORY 12.5 mg

December 8, 1998

PHARMATECH MEDICAL ENTERPRISE PTE LTD

PHARMATECH MEDICAL ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence HolderPHARMATECH MEDICAL ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SUPPOSITORY

RECTAL

Medical Information

M01AB05

diclofenac

Manufacturer Information

PHARMATECH MEDICAL ENTERPRISE PTE. LTD.

BEXIMCO PHARMACEUTICALS LTD

Active Ingredients

DICLOFENAC SODIUM

12.5 mg

Diclofenac

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ULTRAFEN 12.5 SUPPOSITORY 12.5 mg - HSA Approval | MedPath